|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
32,633,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,434,166 |
Avg
Vol: |
665,294 |
52
Week Range: |
$21.74 - $21.74 |
|
Level
I Sector: |
Industrials |
Level
II Sector: |
Diversified Services |
Level
III Sector: |
Research Services |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Henderson Lori M |
SVP, Secretary & Gen Counsel |
|
2017-03-02 |
4 |
D |
$14.52 |
$6,273 |
D/D |
(432) |
61,995 |
|
- |
|
Ladin Felicia I |
SVP, Treasurer & CFO |
|
2017-02-17 |
4 |
D |
$18.71 |
$39,235 |
D/D |
(2,097) |
58,936 |
|
- |
|
Henderson Lori M |
SVP, Secretary & Gen Counsel |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,737 |
62,427 |
|
- |
|
Svokos George |
Chief Operating Officer |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,206 |
122,123 |
|
- |
|
Deming David H |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
6,838 |
|
- |
|
Boyer Milton |
SVP, Drug Product Manufacturin |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,661 |
39,763 |
|
- |
|
Marth William S |
President and CEO |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
47,542 |
521,004 |
|
- |
|
Hagen Kenneth Paul |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
6,838 |
|
- |
|
Fine Margalit |
Executive Vice President, API |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,725 |
7,725 |
|
- |
|
Maddaluna Anthony J |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
11,210 |
|
- |
|
Conway Christopher M. |
SVP, Discovery and Development |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,488 |
45,501 |
|
- |
|
Hagen Steven R |
SVP Manufacturing & Pharmaceut |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,459 |
40,867 |
|
- |
|
Ryan Una S |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
46,845 |
|
- |
|
Gutierrez Fuentes Luis Gerardo |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
6,656 |
|
- |
|
Roth Arthur J |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
47,575 |
|
- |
|
Oconnor Kevin |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
53,275 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, Board of Directors |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
2,478,089 |
|
- |
|
Napolitano Fernando |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
3,802 |
|
- |
|
Ladin Felicia I |
SVP, Treasurer & CFO |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
16,640 |
61,033 |
|
- |
|
Henderson Lori M |
SVP, Secretary & Gen Counsel |
|
2017-02-04 |
4 |
D |
$18.52 |
$65,579 |
D/D |
(3,541) |
46,690 |
|
- |
|
Marth William S |
President and CEO |
|
2017-02-04 |
4 |
D |
$18.52 |
$806,879 |
D/D |
(43,568) |
473,462 |
|
- |
|
Conway Christopher M. |
SVP, Discovery and Development |
|
2017-02-04 |
4 |
D |
$18.52 |
$54,523 |
D/D |
(2,944) |
38,013 |
|
- |
|
Ladin Felicia I |
SVP, Treasurer & CFO |
|
2017-02-04 |
4 |
D |
$18.52 |
$12,131 |
D/D |
(655) |
44,393 |
|
- |
|
Svokos George |
Chief Operating Officer |
|
2017-02-04 |
4 |
D |
$18.52 |
$69,043 |
D/D |
(3,728) |
101,917 |
|
- |
|
Hagen Steven R |
SVP Manufacturing & Pharmaceut |
|
2017-02-04 |
4 |
D |
$18.52 |
$63,764 |
D/D |
(3,443) |
30,408 |
|
- |
|
292 Records found
|
|
Page 2 of 12 |
|
|